10:19 AM EST - Resverlogix Corp. : Announced today its participation during the following leading scientific conferences: American Society of Nephrology (ASN) Kidney Week Reimagined 2020, 13 th Clinical Trials on Alzheimer's Disease (CTAD) digital event, and the American Heart Association (AHA) Scientific Sessions virtual experience, featuring OnDemand oral presentations on apabetalone. Resverlogix Corp.
shares T.RVX are trading up $0.08 at $1.20.
